+ 1-971-202-1575 , TollFree:+ 1-800-910-6452
  [email protected]
Clarient, Inc. - Strategic SWOT Analysis Review
  • Published : January , 2014
  • |
  • Number of Pages : 27
  • |
  • Published By : GlobalData



Report Overview
Clarient, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Clarient Inc. (Clarient) is a cancer diagnostic laboratory services provider. It provides oncology testing and other diagnostics services. The company offers detailed information to characterize and assess cancer for accurate diagnosis and effective treatment. It offers its services to oncologists, pathologists, hospitals and bio-pharmaceutical companies. The company focuses on the most common types of solid tumors such as breast, ovarian, prostate, lung and colon. Clarient also develops new, proprietary companion diagnostic markers for therapeutics in breast, prostate, lung and colon cancers, and leukemia/ lymphoma. It is a wholly-owned subsidiary of GE Healthcare Ltd.

Clarient, Inc. Key Recent Developments

Jul 10, 2013: Clarient, A GE Healthcare Company, Introduces First Lab Developed Test To Assess Multiple Proteins at Single-Cell Leveln

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.



Similar Market Studies

PUBLISHED REPORTS


UPCOMING REPORTS


Reports and Intelligence


We Accept

  • Stay Connected

Copyright ©2017 Reportsandintelligence All Rights Reserved